SRS-A mediated bronchospasm by pharmacologic modification of lung anaphylaxis in vivo

Agents and Actions
D M RitchieM E Rosenthale

Abstract

Antigen challenge of actively sensitized guinea pigs results in the release of histamine eicosanoids (products of the cyclooxygenase pathway of arachidonic acid metabolism) and slow reducing substance of anaphylaxis (SRS-A). By antagonizing the effects of histamine, serotonin, and acetylcholine, inhibiting the cyclooxygenase pathway and supplying arachidonic acid as substrate, the contribution of SRS-A to anaphylactic bronchospasm can be enhanced, thus allowing suitable quantitation of antagonists. This SRS-A mediated bronchospasm can be inhibited in a dose dependent fashion by FPL55712, a selective antagonist of SRS-A. This system represents an in vivo method capable of detecting compounds which inhibit SRS-A synthesis/release of SRS-A action at the effector organ.

References

May 7, 1982·European Journal of Pharmacology·R GreenbergT Steinbacher
Apr 28, 1993·European Journal of Pharmacology·N NakagawaH Aishita
May 12, 1993·European Journal of Pharmacology·T YamaguchiY Iizuka
Jun 24, 1993·European Journal of Pharmacology·K ItohK Matsuda
Aug 3, 1993·European Journal of Pharmacology·K ItohY Iizuka
Jul 1, 1983·Prostaglandins·R P CarraherJ L McGuire
Mar 1, 1987·Journal of Pharmacological Methods·A N Payne, G de Nucci
Jan 1, 1987·International Journal of Immunopharmacology·R L AdolphsonL J Robichaud
Sep 1, 1985·American Journal of Obstetrics and Gynecology·D W HahnL M Demers
May 1, 1994·Prostaglandins, Leukotrienes, and Essential Fatty Acids·J W KaranianN Salem
Mar 15, 1986·Biochemical Pharmacology·J R BeetensF De Clerck
Jan 1, 1996·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·J M YanniD A Gamache

Citations

Oct 1, 1977·Proceedings of the National Academy of Sciences of the United States of America·B A JakschikC W Parker
Sep 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·R C MurphyB Samuelsson
Jan 1, 1977·Pharmacology & Therapeutics. Part B: General & Systematic Pharmacology·P J Piper
Jan 1, 1978·International Archives of Allergy and Applied Immunology·R D Krell, L W Chakrin
Jan 1, 1979·The Journal of Allergy and Clinical Immunology·C W Parker
Dec 1, 1978·The Journal of Allergy and Clinical Immunology·R PattersonK E Harris
Oct 1, 1979·Agents and Actions·K Forsberg, L Sörenby
Nov 17, 1977·Nature·G K Adams, L M Lichtenstein
Jan 1, 1976·International Archives of Allergy and Applied Immunology·J F Burka, P Eyre
Oct 17, 1973·Nature: New Biology·J AugsteinM L Tattersall
Jun 1, 1967·British Journal of Pharmacology and Chemotherapy·H O COLLIER, G W James
Aug 1, 1964·British Journal of Pharmacology and Chemotherapy·P A BERRY, H O COLLIER

Related Concepts

Histamine Measurement
Anaphylaxis (Non Medication)
Lung
Serotonin Measurement
Arachidonic Acid
Cavia
Serotonin
Arachidonic Acid Metabolic Process
Antagonist Muscle Action
Bronchial Spasm

Related Feeds

Anaphylaxis

Anaphylaxis is a serious allergic reaction that is rapid in onset and may cause death.